Mar 25, 2013, 09.13 AM | Source: Reuters
Eye care company Bausch & Lomb Holdings Inc, owned by private equity firm Warburg Pincus, filed with US regulators to raise upto USD 100 million in an initial public offering.
The proposed IPO could raise as much as USD 1.5 billion and is expected to value Bausch & Lomb at about USD 9 billion to USD 10 billion, Reuters reported earlier in March.
In a filing with the US Securities and Exchange Commission on Friday, the company said JP Morgan, BofA Merrill Lynch and Citigroup were the lead underwriters of the offering. (http://link.reuters.com/keh86t)
Warburg Pincus continues to explore a private sale of the company and is working with Goldman Sachs to find a buyer, a source had told Reuters.
Founded in 1853, Rochester, New York-based Bausch & Lomb makes contact lenses, eye drugs and surgical equipment and sells its products in more than 100 countries.
It was taken private by Warburg Pincus in 2007 for about USD 4.5 billion, including USD 830 million of debt, after it fell out of Wall Street's favor because of product recalls, big charges and restatements of earnings. Warburg Pincus committed over USD 1 billion of equity toward the buyout.
The filing did not reveal how many shares would be on sale or their expected price. The amount of money a company says it plans to raise in its first IPO filings is used to calculate registration fees. The final size of the IPO could be different.
After a positive opening, the stock further gained
The shares will be listed on the SME platforms of
Vishal Malkan of malkansview.com is of the view th
The Coimbatore-based firm, which had filed its dra
The IPO is scheduled to close on April 29, as per
L&T Finance Holdings is eyeing stake in state-run
HeidelbergCement India has reported a sales turnov
Medi-Caps has reported a sales turnover of Rs 6.77